A possible role for low-dose cyclosporine in refractory immune thrombocytopenic purpura

Haematologica. 2008 Jul;93(7):1113-5. doi: 10.3324/haematol.12741. Epub 2008 May 27.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived
  • Blood Platelets / drug effects
  • Cyclosporine / administration & dosage*
  • Female
  • Hematology / methods
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Male
  • Middle Aged
  • Purpura, Thrombocytopenic / drug therapy*
  • Risk
  • Rituximab
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunosuppressive Agents
  • Rituximab
  • Cyclosporine